{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T02:37:45Z","timestamp":1779158265357,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,2,8]],"date-time":"2012-02-08T00:00:00Z","timestamp":1328659200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1007\/s12072-012-9350-y","type":"journal-article","created":{"date-parts":[[2012,2,7]],"date-time":"2012-02-07T11:39:58Z","timestamp":1328614798000},"page":"208-214","source":"Crossref","is-referenced-by-count":9,"title":["Copy-number variations in hepatoblastoma associate with unique clinical features"],"prefix":"10.1007","volume":"7","author":[{"given":"Jia-Feng","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Huei","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huey-Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yen-Hsuan","family":"Ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Yuan","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinn-Chyuan","family":"Sheu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daw-Jen","family":"Tsuei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei-Hwei","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,2,8]]},"reference":[{"key":"9350_CR1","doi-asserted-by":"crossref","unstructured":"Chiu SN, Ni YH, Lu MY et al. A trend of improved survival of childhood hepatoblastoma treated with cisplatin and doxorubicin in Taiwanese children. Pediatr Surg Int 2003;19:593\u2013597","DOI":"10.1007\/s00383-003-1032-3"},{"key":"9350_CR2","doi-asserted-by":"crossref","unstructured":"Chang MH, Chen TH, Hsu HM et al. Prevention of hepatocellular carcinoma by universal vaccination against hepatitis B virus: the effect and problems. Clin Cancer Res 2005;11:7953\u20137957","DOI":"10.1158\/1078-0432.CCR-05-1095"},{"key":"9350_CR3","doi-asserted-by":"crossref","unstructured":"Chang MH, Chen CJ, Lai MS et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med 1997;336:1855\u20131859","DOI":"10.1056\/NEJM199706263362602"},{"key":"9350_CR4","doi-asserted-by":"crossref","unstructured":"Fukuzawa R, Hata J, Hayashi Y et al. Beckwith\u2013Wiedemann syndrome-associated hepatoblastoma: wnt signal activation occurs later in tumorigenesis in patients with 11p15.5 uniparental disomy. Pediatr Dev Pathol 2003;6:299\u2013306","DOI":"10.1007\/s10024-003-1009-1"},{"key":"9350_CR5","doi-asserted-by":"crossref","unstructured":"Hirschman BA, Pollock BH, Tomlinson GE The spectrum of APC mutations in children with hepatoblastoma from familial adenomatous polyposis kindreds. J Pediatr 2005;147:263\u2013266","DOI":"10.1016\/j.jpeds.2005.04.019"},{"key":"9350_CR6","doi-asserted-by":"crossref","unstructured":"Parada LA, Limon J, Iliszko M et al. Cytogenetics of hepatoblastoma: further characterization of 1q rearrangements by fluorescence in situ hybridization: an international collaborative study. Med Pediatr Oncol 2000;34:165\u2013170","DOI":"10.1002\/(SICI)1096-911X(200003)34:3<165::AID-MPO1>3.0.CO;2-T"},{"key":"9350_CR7","doi-asserted-by":"crossref","unstructured":"Ali W, Savasan S, Rabah R et al. Cytogenetic findings in two new cases of hepatoblastoma. Cancer Genet Cytogenet 2002;133:179\u2013182","DOI":"10.1016\/S0165-4608(01)00588-X"},{"key":"9350_CR8","doi-asserted-by":"crossref","unstructured":"Sandoval C, Piper J, Mowery-Rushton PA et al. Fetal-type hepatoblastoma and del(3)(q11.2q13.2). Cancer Genet Cytogenet 2002;134:162\u2013164","DOI":"10.1016\/S0165-4608(01)00622-7"},{"key":"9350_CR9","doi-asserted-by":"crossref","unstructured":"Weber RG, Pietsch T, von Schweinitz D et al. Characterization of genomic alterations in hepatoblastomas. A role for gains on chromosomes 8q and 20 as predictors of poor outcome. Am J Pathol 2000;157:571\u2013578","DOI":"10.1016\/S0002-9440(10)64567-1"},{"key":"9350_CR10","doi-asserted-by":"crossref","unstructured":"Gray SG, Kyt\u00f6l\u00e4 S, Matsunaga T et al. Comparative genomic hybridization reveals population-based genetic alterations in hepatoblastomas. Br J Cancer 2000;83:1020\u20131025","DOI":"10.1054\/bjoc.2000.1390"},{"key":"9350_CR11","doi-asserted-by":"crossref","unstructured":"Kumon K, Kobayashi H, Namiki T et al. Frequent increase of DNA copy number in the 2q24 chromosomal region and its association with a poor clinical outcome in hepatoblastoma: cytogenetic and comparative genomic hybridization analysis. Jpn J Cancer Res 2001;92:854\u2013862","DOI":"10.1111\/j.1349-7006.2001.tb01172.x"},{"key":"9350_CR12","doi-asserted-by":"crossref","unstructured":"Suzuki M, Kato M, Yuyan C et al. Whole-genome profiling of chromosomal aberrations in hepatoblastoma using high-density single-nucleotide polymorphism genotyping microarrays. Cancer Sci 2008;99:564\u2013570","DOI":"10.1111\/j.1349-7006.2007.00710.x"},{"key":"9350_CR13","doi-asserted-by":"crossref","unstructured":"Stejskalov\u00e1 E, Malis J, Snajdauf J et al. Cytogenetic and array comparative genomic hybridization analysis of a series of hepatoblastomas. Cancer Genet Cytogenet 2009;194:82\u201387","DOI":"10.1016\/j.cancergencyto.2009.06.001"},{"key":"9350_CR14","doi-asserted-by":"crossref","unstructured":"Czauderna P, Otte JB, Aronson DC et al. Guidelines for surgical treatment of hepatoblastoma in the modern era\u2014recommendations from the Childhood Liver Tumour Strategy Group of the International Society of Paediatric Oncology (SIOPEL). Eur J Cancer 2005;41:1031\u20131036","DOI":"10.1016\/j.ejca.2005.02.004"},{"key":"9350_CR15","doi-asserted-by":"crossref","unstructured":"Pritchard J, Brown J, Shafford E et al. Cisplatin, doxorubicin, and delayed surgery for childhood hepatoblastoma: a successful approach\u2014results of the first prospective study of the International Society of Pediatric Oncology. J Clin Oncol 2000;18:3819\u20133828","DOI":"10.1200\/JCO.2000.18.22.3819"},{"key":"9350_CR16","doi-asserted-by":"crossref","unstructured":"Lee CH, Wu CC, Wu YN et al. Gene copy number variations in Asian patients with congenital bilateral absence of the vas deferens. Hum Reprod 2009;24:748\u2013755","DOI":"10.1093\/humrep\/den413"},{"key":"9350_CR17","doi-asserted-by":"crossref","unstructured":"Lee CH, Fang CY, Sheu JJ et al. Amplicons on chromosome 3 contain oncogenes induced by recurrent exposure to 12-O-tetradecanoylphorbol-13-acetate and sodium n-butyrate and Epstein-Barr virus reactivation in a nasopharyngeal carcinoma cell line. Cancer Genet Cytogenet 2008;185:1\u201310","DOI":"10.1016\/j.cancergencyto.2008.03.014"},{"key":"9350_CR18","doi-asserted-by":"crossref","unstructured":"Lee CH, Liu CM, Wen CC et al. Genetic copy number variants in sib pairs both affected with schizophrenia. J Biomed Sci 2010;17:2","DOI":"10.1186\/1423-0127-17-2"},{"key":"9350_CR19","doi-asserted-by":"crossref","unstructured":"Edgar R, Domrachev M, Lash AE Gene Expression Omnibus. NCBI gene expression and hybridization array data repository. Nucleic Acids Res 2002;30:207\u2013210","DOI":"10.1093\/nar\/30.1.207"},{"key":"9350_CR20","doi-asserted-by":"crossref","unstructured":"Maruyama K, Ikeda H, Koizumi T Hepatoblastoma associated with trisomy 18 syndrome: a case report and a review of the literature. Pediatr Int 2001;43:302\u2013305","DOI":"10.1046\/j.1442-200x.2001.01380.x"},{"key":"9350_CR21","doi-asserted-by":"crossref","unstructured":"Hashizume K, Nakajo T, Kawarasaki H et al. Prader-Willi syndrome with del(15)(q11,q13) associated with hepatoblastoma. Acta Paediatr Jpn 1991;33:718\u2013722","DOI":"10.1111\/j.1442-200X.1991.tb02597.x"},{"key":"9350_CR22","doi-asserted-by":"crossref","unstructured":"Yamamoto Y, Chochi Y, Matsuyama H et al. Gain of 5p15.33 is associated with progression of bladder cancer. Oncology 2007;72:132\u2013138","DOI":"10.1159\/000111132"},{"key":"9350_CR23","doi-asserted-by":"crossref","unstructured":"Kang JU, Koo SH, Kwon KC et al. Gain at chromosomal region 5p15.33, containing TERT, is the most frequent genetic event in early stages of non-small cell lung cancer. Cancer Genet Cytogenet 2008;182:1\u201311","DOI":"10.1016\/j.cancergencyto.2007.12.004"},{"key":"9350_CR24","doi-asserted-by":"crossref","unstructured":"Hwang KT, Han W, Cho J et al. Genomic copy number alterations as predictive markers of systemic recurrence in breast cancer. Int J Cancer 2008;123:1807\u20131815","DOI":"10.1002\/ijc.23672"},{"key":"9350_CR25","doi-asserted-by":"crossref","unstructured":"Lu Y, Yu Y, Zhu Z et al. Identification of a new target region by loss of heterozygosity at 5p15.33 in sporadic gastric carcinomas: genotype and phenotype related. Cancer Lett 2005;224:329\u2013337","DOI":"10.1016\/j.canlet.2004.11.057"},{"key":"9350_CR26","doi-asserted-by":"crossref","unstructured":"Schmutz J, Martin J, Terry A et al. The DNA sequence and comparative analysis of human chromosome 5. Nature 2004;431:268\u2013274","DOI":"10.1038\/nature02919"},{"key":"9350_CR27","doi-asserted-by":"crossref","unstructured":"Yan B, Matoney L, Yang D Human carboxylesterases in term placentae: enzymatic characterization, molecular cloning and evidence for the existence of multiple forms. Placenta 1999;20:599\u2013607","DOI":"10.1053\/plac.1999.0407"},{"key":"9350_CR28","doi-asserted-by":"crossref","unstructured":"Wheelock CE, Phillips BM, Anderson BS et al. Applications of carboxylesterase activity in environmental monitoring and toxicity identification evaluations (TIEs). Rev Environ Contam Toxicol 2008;195:117\u2013178","DOI":"10.1007\/978-0-387-77030-7_5"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-012-9350-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12072-012-9350-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-012-9350-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T03:37:11Z","timestamp":1559446631000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12072-012-9350-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,8]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["9350"],"URL":"https:\/\/doi.org\/10.1007\/s12072-012-9350-y","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,8]]}}}